Discontinuation report MYLAN-TOLTERODINE ER
Report ID | 155040 |
Drug Identification Number | 02404192 |
Brand name | MYLAN-TOLTERODINE ER |
Common or Proper name | TOLTERODINE TARTRATE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | TOLTERODINE TARTRATE |
Strength(s) | 4MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL |
Packaging size | 30BT, 100BT |
ATC code | G04BD |
ATC description | OTHER UROLOGICALS, INCL ANTISPASMODICS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2022-02-14 |
Remaining supply date | 2022-02-14 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | Discontinued in shortage ID 25895. Last lot 3082332 Expiry November-30-2018 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2022-02-15 | French | Compare |
v1 | 2022-02-15 | English | Compare |
Showing 1 to 2 of 2